Justifying and reporting the use of stress protocols in pre‐clinical experiments that use animals
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Andria Michael, Anna Onisiforou, Polymnia Georgiou, Morfeas Koumas, Chris Powels, Elmar Mammadov, Andrea N. Georgiou, Panos Zanos |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Justifying and reporting the use of severe stress in experiments that use animals
por: S. Clare Stanford, et al.
Publicado: (2026)
por: S. Clare Stanford, et al.
Publicado: (2026)
Response to: Justifying and reporting the use of severe stress in experiments that use animals
por: Charles Whalley, et al.
Publicado: (2026)
por: Charles Whalley, et al.
Publicado: (2026)
Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
por: Thi Viet Ha Nguyen, et al.
Publicado: (2025)
por: Thi Viet Ha Nguyen, et al.
Publicado: (2025)
Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology
por: Lucas Wittenkeller, et al.
Publicado: (2025)
por: Lucas Wittenkeller, et al.
Publicado: (2025)
Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouse
por: Fabien Xuereb, et al.
Publicado: (2025)
por: Fabien Xuereb, et al.
Publicado: (2025)
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience
por: Juliette A. van den Noort, et al.
Publicado: (2025)
por: Juliette A. van den Noort, et al.
Publicado: (2025)
Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis
por: Guendalina Olivero, et al.
Publicado: (2024)
por: Guendalina Olivero, et al.
Publicado: (2024)
Apixaban anti‐Xa levels in clinical practice: A case report
por: Sarah Clark, et al.
Publicado: (2024)
por: Sarah Clark, et al.
Publicado: (2024)
The opioid partial agonist PPL‐138 reduces alcohol self‐administration in rats susceptible to post‐traumatic stress disorder
por: Andrea Cippitelli, et al.
Publicado: (2025)
por: Andrea Cippitelli, et al.
Publicado: (2025)
Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour
por: Non Davies, et al.
Publicado: (2025)
por: Non Davies, et al.
Publicado: (2025)
Mindfulness‐Oriented Recovery Enhancement: Implementing an evidence‐based intervention for chronic pain, opioid use, and opioid addiction in clinical settings
por: Eric L. Garland
Publicado: (2024)
por: Eric L. Garland
Publicado: (2024)
Ethosuximide: Subunit‐ and Gβγ‐dependent blocker and reporter of allosteric changes in GIRK channels
por: Boris Shalomov, et al.
Publicado: (2025)
por: Boris Shalomov, et al.
Publicado: (2025)
Correction to “Naltrexone‐bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.”
por: Igho J. Onakpoya
Publicado: (2024)
por: Igho J. Onakpoya
Publicado: (2024)
Analysis of longitudinal patterns and predictors of medicine use in residential aged care using group‐based trajectory modelling: The MEDTRAC‐Polypharmacy longitudinal cohort study
por: Nasir Wabe, et al.
Publicado: (2024)
por: Nasir Wabe, et al.
Publicado: (2024)
Digital twins: Unlocking comparative evidence that clinical research urgently needs
por: Andrej Belančić, et al.
Publicado: (2025)
por: Andrej Belančić, et al.
Publicado: (2025)
Comment on ‘Spotlight commentary: Addressing the persistent problem of benzodiazepine overuse, time for clinical, educational and AI‐driven reform’
por: Jennifer Koenig, et al.
Publicado: (2026)
por: Jennifer Koenig, et al.
Publicado: (2026)
Sentinel dosing: A proposed algorithm to guide decision making on which cohorts in early phase clinical pharmacology trials should use this approach
por: Jules A. A. C. Heuberger, et al.
Publicado: (2025)
por: Jules A. A. C. Heuberger, et al.
Publicado: (2025)
Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing
por: Marcel Schulz, et al.
Publicado: (2024)
por: Marcel Schulz, et al.
Publicado: (2024)
Assessing GPT‐4's accuracy in answering clinical pharmacological questions on pain therapy
por: Anna Stroop, et al.
Publicado: (2025)
por: Anna Stroop, et al.
Publicado: (2025)
Why and how do we perform physical examination(s) in clinical trials? A use case of drug intervention trials in type 2 diabetes mellitus
por: Julia Kopanz, et al.
Publicado: (2025)
por: Julia Kopanz, et al.
Publicado: (2025)
Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis
por: Javier Milara, et al.
Publicado: (2024)
por: Javier Milara, et al.
Publicado: (2024)
Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase
por: Comfort Kunak Ogar, et al.
Publicado: (2026)
por: Comfort Kunak Ogar, et al.
Publicado: (2026)
TRPA1 up‐regulation mediates oxidative stress in a pulpitis model in vitro
por: Árpád Kunka, et al.
Publicado: (2024)
por: Árpád Kunka, et al.
Publicado: (2024)
The use of different types of networks, alone and in combination, for drug target identification
por: Paolo Parini
Publicado: (2025)
por: Paolo Parini
Publicado: (2025)
The Australia story: Current status and future challenges for the clinical applications of psychedelics
por: David J Nutt, et al.
Publicado: (2024)
por: David J Nutt, et al.
Publicado: (2024)
Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study
por: Noora Nieminen, et al.
Publicado: (2026)
por: Noora Nieminen, et al.
Publicado: (2026)
Overcoming barriers to adherence through innovative injectable medications: A systematic review of therapeutic options for cardiovascular disease, reported adherence, and perspectives on their use
por: Beata Bajorek, et al.
Publicado: (2025)
por: Beata Bajorek, et al.
Publicado: (2025)
Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study
por: Sam Schoenmakers, et al.
Publicado: (2025)
por: Sam Schoenmakers, et al.
Publicado: (2025)
A comment on the interpretation of ligand binding experiments for agonists
por: James P. Higham
Publicado: (2025)
por: James P. Higham
Publicado: (2025)
Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation
por: Chun‐Yu Lo, et al.
Publicado: (2025)
por: Chun‐Yu Lo, et al.
Publicado: (2025)
Fn14 signalling participates in pristane‐induced murine lupus through exacerbating oxidative stress
por: Zhu Yan, et al.
Publicado: (2026)
por: Zhu Yan, et al.
Publicado: (2026)
SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines
por: Hong‐Xia Guo, et al.
Publicado: (2025)
por: Hong‐Xia Guo, et al.
Publicado: (2025)
PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study)
por: Marta Di Salvo, et al.
Publicado: (2024)
por: Marta Di Salvo, et al.
Publicado: (2024)
Compound 4a induces paraptosis in liver cancer through endoplasmic reticulum stress mediated by the calreticulin protein
por: Chunmiao Wang, et al.
Publicado: (2024)
por: Chunmiao Wang, et al.
Publicado: (2024)
Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pregnant women with HIV
Publicado: (2024)
Publicado: (2024)
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
por: Valentina Giunchi, et al.
Publicado: (2025)
por: Valentina Giunchi, et al.
Publicado: (2025)
Best practices for blood collection and anaesthesia in mice: Selection, application and reporting
por: Zhixin Li, et al.
Publicado: (2025)
por: Zhixin Li, et al.
Publicado: (2025)
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline
por: Masaya Hasegawa, et al.
Publicado: (2024)
por: Masaya Hasegawa, et al.
Publicado: (2024)
Modulation of K ATP channels by diazoxide preserves mitochondrial function and barrier integrity under staurosporine‐induced epithelial stress
por: Fatima Maqoud, et al.
Publicado: (2026)
por: Fatima Maqoud, et al.
Publicado: (2026)
Memantine prevents acute stress‐induced memory deficits by reversing sex‐dependent pathophysiological glutamatergic alterations in the dorsal hippocampus
por: Sebastiano A. Torrisi, et al.
Publicado: (2026)
por: Sebastiano A. Torrisi, et al.
Publicado: (2026)
Ejemplares similares
-
Justifying and reporting the use of severe stress in experiments that use animals
por: S. Clare Stanford, et al.
Publicado: (2026) -
Response to: Justifying and reporting the use of severe stress in experiments that use animals
por: Charles Whalley, et al.
Publicado: (2026) -
Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
por: Thi Viet Ha Nguyen, et al.
Publicado: (2025) -
Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology
por: Lucas Wittenkeller, et al.
Publicado: (2025) -
Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouse
por: Fabien Xuereb, et al.
Publicado: (2025)